Multiple sclerosis (MS) is an immunological disease that causes acute inflammatory lesions
and chronic inflammation in the CNS, leading to tissue damage and disability. As awareness …

An increased interest in population-based registries and databases will provide more valid
epidemiological measures and observational studies conducted in well-defined study …

Background: The presenting symptoms and rate of progression of multiple sclerosis (MS)
are very heterogeneous. The diverse clinical manifestations and the clinical course of the …

Major advancements have been achieved in our ability to diagnose multiple sclerosis (MS)
and to commence treatment intervention with agents that can favorably affect the disease …

Who Is Affected by and at Risk of MS? About 900 000 people in the US have MS. Onset of
symptoms typically occurs at age 20 to 30 years. Women are nearly 3 times more likely to …

Multiple sclerosis (MS) is an inflammatory-mediated demyelinating disease of the human
central nervous system. The clinical disease course is variable, usually starts with reversible …

Multiple sclerosis (MS) is the commonest disabling neurological condition to afflict young
adults and therefore has a high social burden. Over several decades, there has been a …

Multiple sclerosis (MS) is an immune-inflammatory disease that attacks and damages
myelinated axons in the central nervous system (CNS) and causes nontraumatic …

Multiple sclerosis (MS) is a chronic inflammatory condition of the central nervous system
determined by a presumed autoimmune process mainly directed against myelin …

Background Multiple sclerosis (MS) is a chronic and autoimmune disease of the central
nervous system (CNS), mainly characterized by inflammatory demyelination, which …